United States · FDA National Drug Code directory
bupropion
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65841-836_6c831525-a7c2-4ef1-b1b9-c7e8cb807ded
- Product NDC
- 65841-836
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- bupropion
- Labeler
- Zydus Lifesciences Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180802
- Source listing expiry
- 20261231
Source-listed ingredients
- BUPROPION HYDROCHLORIDE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-836-05) · 65841-836-05
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-836-06) · 65841-836-06
- 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-836-10) · 65841-836-10
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-836-16) · 65841-836-16
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →